KOPECKA, Joanna

KOPECKA, Joanna  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
Cardiac glycosides as new modulators of cholesterol metabolism 2012 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 2013 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 2012 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Digoxin and oubain increase the synthesis of cholesterol in human liver cells 2011 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target 2016 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
The Hypoxia-Inducible Factor-1 alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance 2015 Griggio, V; Vitale, C; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Del Poeta, G; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 2010 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. 2014 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 2011 M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 2011 Manuela Polimeni; Claudia Voena; Johanna Kopecka; Chiara Riganti; Gianpiero Pescarmona; Amalia Bosia; Dario Ghigo
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 2011 M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 2013 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells 2012 I. Campia ; J.Kopecka; M.L. Pinzon; D. Ghigo; C. Riganti
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 2018 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, AA; Laurenti, L; Del Poeta, G; Mauro, FR; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 2016 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE 2017 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target 2018 Griggio V, Vitale C, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Rossi D, Pozzato G, Marchetti M, Omede’ P, Bonello L, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Gattei V, Gaidano G, Foa’ R, Massaia M, Boccadoro M, Coscia M
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 2020 Griggio V, Vitale C, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Rossi D, Pozzato G, Marchetti M, Omedé P, Bonello L, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Gattei V, Gaidano G, Foa’ R, Massaia M, Boccadoro M, Coscia M
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 2018 Vitale C, Griggio V, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Rossi D, Pozzato G, Marchetti M, Omede’ P, Bonello L, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Gattei V, Gaidano G, Foa’ R, Massaia M, Boccadoro M, Coscia M
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells. 2012 Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti